Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
Cisplatin is a chemotherapeutic drug used to treat a variety of cancers. Both intrinsic and acquired resistance to cisplatin, as well as toxicity, limit its effectiveness. Molecular mechanisms that underlie cisplatin resistance are poorly understood. Here we demonstrate that deletion of the yeast CTR1 gene, which encodes a high-affinity copper transporter, results in increased cisplatin resistance and reduced intracellular accumulation of cisplatin. Copper, which causes degradation and internalization of Ctr1 protein (Ctr1p), enhances survival of wild-type yeast cells exposed to cisplatin and reduces cellular accumulation of the drug. Cisplatin also causes degradation and delocalization of Ctr1p and interferes with copper uptake in wild-type yeast cells. Mouse cell lines lacking one or both mouse Ctr1 ( mCtr1 ) alleles exhibit increased cisplatin resistance and decreased cisplatin accumulation in parallel with mCtr1 gene dosage. We propose that cisplatin uptake is mediated by the copper transporter Ctr1p in yeast and mammals. The link between Ctr1p and cisplatin transport may explain some cases of cisplatin resistance in humans and suggests ways of modulating sensitivity and toxicity to this important anticancer drug.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Longtine, M. S., Mckenzie III, A., Demarini, D. J., Shah, N. G., Wach, A., Brachat, A., Philippsen, P., & Pringle, J. R. (1998) · Yeast · doi:10.1002/(sici)1097-0061(199807)14:10<953::aid-yea293>3.0.co;2-u · Cited by 5,345
Fichtinger-Schepman, A. M. J., Van der Veer, J. L., Den Hartog, J. H. J., Lohman, P. H. M., & Reedijk, J. (1985) · Biochemistry · doi:10.1021/bi00324a025 · Cited by 1,024
LOEHRER, P. J., & EINHORN, L. H. (1984) · Annals of Internal Medicine · doi:10.7326/0003-4819-100-5-704 · Cited by 947
Dancis, A., Yuan, D. S., Haile, D., Askwith, C., Eide, D., Moehle, C., Kaplan, J., & Klausner, R. D. (1994) · Cell · doi:10.1016/0092-8674(94)90345-x · Cited by 659
Biochemical Characterization of the Human Copper Transporter Ctr1
Lee, J., Peña, M. M. O., Nose, Y., & Thiele, D. J. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m104728200 · Cited by 608
Self-citationCellular accumulation of the anticancer agent cisplatin: A review
Gately, D., & Howell, S. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.221 · Cited by 572
h CTR1: A human gene for copper uptake identified by complementation in yeast
Zhou, B., & Gitschier, J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.14.7481 · Cited by 567
Cisplatin and DNA repair in cancer chemotherapy
Zamble, D. B., & Lippard, S. J. (1995) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(00)89095-7 · Cited by 538
Burns, N., Grimwade, B., Ross-Macdonald, P. B., Choi, E. Y., Finberg, K., Roeder, G. S., & Snyder, M. (1994) · Genes & Development · doi:10.1101/gad.8.9.1087 · Cited by 490
Essential role for mammalian copper transporter Ctr1 in copper homeostasis and embryonic development
Lee, J., Prohaska, J. R., & Thiele, D. J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.111058698 · Cited by 472
Self-citationDancis, A., Haile, D., Yuan, D. S., & Klausner, R. D. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47300-0 · Cited by 400
Clinical Perspectives on Platinum Resistance
Giaccone, G. (2000) · Drugs · doi:10.2165/00003495-200059004-00002 · Cited by 364
Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.
Komatsu, M., Sumizawa, T., Mutoh, M., Chen, Z., Terada, K., Furukawa, T., Yang, X., Gao, H., Miura, N., Sugiyama, T., et al. (2000) · PubMed · Cited by 328
Jungmann, J., Reins, H. A., Lee, J., Romeo, A., Hassett, R., Kosman, D., & Jentsch, S. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb06198.x · Cited by 283
Self-citationKampfenkel, K., Kushnir, S., Babiychuk, E., Inzé, D., & Van Montagu, M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.47.28479 · Cited by 266
Labbé, S., Zhu, Z., & Thiele, D. J. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.25.15951 · Cited by 252
Self-citationA widespread transposable element masks expression of a yeast copper transport gene.
Knight, S. A., Labbé, S., Kwon, L. F., Kosman, D. J., & Thiele, D. J. (1996) · Genes & Development · doi:10.1101/gad.10.15.1917 · Cited by 248
Self-citationDelivering Copper Inside Yeast and Human Cells
Valentine, J. S., & Gralla, E. B. (1997) · Science · doi:10.1126/science.278.5339.817 · Cited by 230
Ooi, C. E., Rabinovich, E., Dancis, A., Bonifacino, J. S., & Klausner, R. D. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00720.x · Cited by 216
Lee, J., Prohaska, J. R., Dagenais, S. L., Glover, T. W., & Thiele, D. J. (2000) · Gene · doi:10.1016/s0378-1119(00)00287-0 · Cited by 203
Self-citationMetalloregulation of FRE1 and FRE2Homologs in Saccharomyces cerevisiae
Martins, L. J., Jensen, L. T., Simon, J. R., Keller, G. L., & Winge, D. R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23716 · Cited by 199
Yamaguchi-Iwai, Y., Serpe, M., Haile, D., Yang, W., Kosman, D. J., Klausner, R. D., & Dancis, A. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.28.17711 · Cited by 187
Ixr1, a Yeast Protein That Binds to Platinated DNA and Confers Sensitivity to Cisplatin
Brown, S. J., Kellett, P. J., & Lippard, S. J. (1993) · Science · doi:10.1126/science.8342024 · Cited by 178
Beck, D. J., & Brubaker, R. R. (1973) · Journal of Bacteriology · doi:10.1128/jb.116.3.1247-1252.1973 · Cited by 168
Kawabe, T., Chen, Z.-S., Wada, M., Uchiumi, T., Ono, M., Akiyama, S.-I., & Kuwano, M. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00979-5 · Cited by 158
Fraval, H. N. A., Rawlings, C., & Roberts, J. J. (1978) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/0027-5107(78)90014-3 · Cited by 156
Hassett, R. F., Dix, D., Eide, D. J., & Kosman, D. J. (2000) · Biochemical Journal · doi:10.1042/0264-6021:3510477 · Cited by 135
The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast
McA'Nulty, M. M., & Lippard, S. J. (1996) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(95)00037-2 · Cited by 112
A series of protein phosphatase gene disruptants inSaccharomyces cerevisiae
Sakumoto, N., Mukai, Y., Uchida, K., Kouchi, T., Kuwajima, J., Nakagawa, Y., Sugioka, S., Yamamoto, E., Furuyama, T., Mizubuchi, H., et al. (1999) · Yeast · doi:10.1002/(sici)1097-0061(199911)15:15<1669::aid-yea480>3.0.co;2-6 · Cited by 108
Reactions of the UVRABC excision nuclease with DNA damaged by diamminedichloroplatinum(II)
Beck, D. J., Popoff, S. C., Sancar, A., & Rupp, W. D. (1985) · Nucleic Acids Research · doi:10.1093/nar/13.20.7395 · Cited by 105
Nucleotide-excision repair of DNA in cell-free extracts of the yeast Saccharomyces cerevisiae.
Wang, Z., Wu, X., & Friedberg, E. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4907 · Cited by 89
Schenk, P. W., Boersma, A. W. M., Brandsma, J. A., den Dulk, H., Burger, H., Stoter, G., Brouwer, J., & Nooter, K. (2001) · PubMed · Cited by 57
Two Nuclear Proteins, Cin5 and Ydr259c, Confer Resistance to Cisplatin in Saccharomyces cerevisiae
Furuchi, T., Ishikawa, H., Miura, N., Ishizuka, M., Kajiya, K., Kuge, S., & Naganuma, A. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.3.470 · Cited by 55
Cited by
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
The resurgence of platinum-based cancer chemotherapy
Kelland, L. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2167 · Cited by 4,717
Cellular processing of platinum anticancer drugs
Wang, D., & Lippard, S. J. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1691 · Cited by 3,801
“Mutation or deletion of the CTR1 gene results in increased cisplatin resistance and reduction of platinum levels in both yeast and mouse cell”
BackgroundMolecular mechanisms of cisplatin resistance
Galluzzi, L., Senovilla, L., Vitale, I., Michels, J., Martins, I., Kepp, O., Castedo, M., & Kroemer, G. (2012) · Oncogene · doi:10.1038/onc.2011.384 · Cited by 2,760
Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies
Pabla, N., & Dong, Z. (2008) · Kidney International · doi:10.1038/sj.ki.5002786 · Cited by 1,918
Metadata
- Authors
- Ishida, S., Lee, J., Thiele, D. J., & Herskowitz, I.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2002-10-07
- Volume
- 99
- Issue
- 22
- Pages
- 14298-14302
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2084492467
- Cited by
- 927
- References
- 33
- FWCI
- 9.60
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.